Fulcrum Therapeutics Inc FULC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:45 AM EDT
26.70quote price arrow down-0.55 (-2.04%)
Volume
89,441
52 week range
6.85 - 33.10
Loading...
  • Open27.40
  • Day High27.55
  • Day Low26.64
  • Prev Close27.26
  • 52 Week High33.10
  • 52 Week High Date09/21/21
  • 52 Week Low6.85
  • 52 Week Low Date07/27/21

Key Stats

  • Market Cap1.05B
  • Shares Out39.31M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.41
  • YTD % Change130.15

KEY STATS

  • Open27.40
  • Day High27.55
  • Day Low26.64
  • Prev Close27.26
  • 52 Week High33.10
  • 52 Week High Date09/21/21
  • 52 Week Low6.85
  • 52 Week Low Date07/27/21
  • Market Cap1.05B
  • Shares Out39.31M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.41
  • YTD % Change130.15

RATIOS/PROFITABILITY

  • EPS (TTM)-2.48
  • P/E (TTM)-10.77
  • Fwd P/E (NTM)-9.93
  • EBITDA (MRQ)-70.959M
  • ROE (MRQ)-62.94%
  • Revenue (MRQ)15.24M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-481.07%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fulcrum Therapeutics Inc

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Fulcrum Therapeutics, Inc. clinical-stage biopharmaceutical company. The Company focuses on improving the lives of patients with genetically defined rare diseases. The Company have developed a product engine which identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The Company is also engaged in developing drugs for the treatment for the root cause of muscle disorders, central nervous system disorders and blood...
Mark Levin
Chairman
Bryan Stuart
President
Curtis Oltmans J.D.
General Counsel
Address
26 Landsdowne St
Cambridge, MA
02139-4216
United States

Top Peers

SYMBOLLASTCHG%CHG
RNA
Avidity Biosciences Inc
22.64-0.65-2.79%
PTGX
Protagonist Therapeutics Inc
18.43-0.72-3.78%
SNDX
Syndax Pharmaceuticals Inc
19.94+0.18+0.91%
PRAX
Praxis Precision Medicines Inc
20.41-0.94-4.40%
GOSS
Gossamer Bio Inc
12.94+0.02+0.15%